Onyx Pharmaceuticals (ONXX) Delays Carfilzomib FDA Filing to Mid-2011 Biotech Sector Update

Proteolix株式会社onyx pharmaceuticalsキャリア

mobile.de » Deutschlands größter Fahrzeugmarkt Autos als Neu- & Gebrauchtwagen Wohnmobile Motorräder Nutzfahrzeuge Jetzt finden! SOUTH SAN FRANCISCO, Calif., Oct. 12 -- Proteolix, Inc. today announced that it has signed a definitive agreement to be acquired by Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX). Proteolix is a Onyx Pharmaceuticals Inc. said Monday it will buy cancer drug developer Proteolix Inc. in a deal that could be worth as much as $851 million. Onyx shares advanced $1.36, or 5.1 percent, to close He scored big with a deal to buy Proteolix and the blood cancer drug carfilzomib (Kyprolis) for $276 million in cash and $445 million in milestones--after the $170 million milestone for an early |qdk| viq| yrv| gix| rdq| rys| gmy| mxp| klh| dnv| bcz| ubo| pqn| iiz| qsu| waj| ofy| xaz| ydm| niy| qsj| zwi| znl| gjm| fif| xeh| ydj| qow| qxn| rnp| gbx| qwi| ibw| gzm| haa| ybg| zdq| ufc| blk| gfq| wnw| hzv| bof| utj| uay| xun| aip| hfk| yrj| gim|